Transgene
Biotechnology ResearchBas-Rhin, France201-500 Employees
Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
Insights
Recent Talent Acquisitions Transgene has been strategically strengthening its leadership team by appointing key executives like Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer. Leveraging these new hires could provide opportunities to pitch innovative cancer immunotherapies to potential partners or investors seeking expertise in the field.
Expansion in Cancer Vaccine Development Transgene's focus on developing a head and neck cancer vaccine, in collaboration with NEC, showcases a commitment to advancing cancer immunotherapy solutions. Highlighting this cutting-edge development could position the company favorably for collaborations with healthcare institutions or pharmaceutical companies looking to invest in novel oncology treatment options.
Financial Recognition and Future Investments Receiving the 'Investment for the Future' award from Bpifrance underscored Transgene's innovative approach and potential for growth. This recognition could be leveraged in sales pitches to attract additional funding or partnerships with organizations that value technological advancement and long-term sustainability.
Promotion of Key Personnel The promotion of Lucie Larguier to Vice President Corporate Communications and Investor Relations signifies a focus on enhancing stakeholder relations and bolstering the company's public image. Building on this promotion, Transgene could explore sales opportunities by showcasing strong leadership and communication strategies to attract potential investors or collaborators seeking transparency and credibility.
Market Differentiation through Strategic Collaborations Collaborating with renowned partners like NEC for vaccine development positions Transgene as a frontrunner in the biotechnology research industry. Emphasizing these strategic alliances in sales propositions could appeal to potential clients or investors looking for companies with a solid network and a track record of successful collaborations in the competitive biotech landscape.
Similar companies to Transgene
Amgen
36K
$1B4D Molecular Therapeutics
222$10M$50MMerck
41K$1BOSE Immunotherapeutics
69$10M$50MTurnstone Biologics
91$10M$50M
Transgene Tech Stack
Transgene uses 8 technology products and services including Site Kit, WordPress, CookieYes, and more. Explore Transgene's tech stack below.
- Site KitAnalytics
- WordPressContent Management System
- CookieYesCookie Compliance
- jQueryJavascript Libraries
- prettyPhotoJavascript Libraries
- Contact Form 7Web Platform Extensions
- GoDaddy CoBlocksWeb Platform Extensions
- TwitterWidgets
Media & News
Transgene's Email Address Formats
Transgene uses at least 1 format(s):
| Transgene Email Formats | Percentage |
| Last@transgene.fr | 64% |
| FirstLast@transgene.fr | 25% |
| First.Last@transgene.fr | 9% |
| F.Last@transgene.fr | 2% |
Frequently Asked Questions
Where is Transgene's headquarters located?
Transgene's main headquarters is located at Illkirch-Graffenstaden, Bas-Rhin 67400 FR. The company has employees across 4 continents, including EuropeAsiaNorth America. What is Transgene's phone number?
You can contact Transgene's main corporate office by phone at +33-3-88-27-9****
What is Transgene's official website and social media links?
Transgene's official website is transgene.fr and has social profiles on LinkedIn.How much revenue does Transgene generate?
As of September 2024, Transgene's annual revenue reached $75M. What is Transgene's SIC code NAICS code?
Transgene's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Transgene have currently?
As of September 2024, Transgene has approximately 209 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Business Officer: J. W.Head Of Process Sciences: S. R.Head Of Vectorology Laboratory: N. S.. Explore Transgene's employee directory with LeadIQ.What industry does Transgene belong to?
Transgene operates in the Biotechnology Research industry. What technology does Transgene use?
Transgene's tech stack includes Site KitWordPressCookieYesjQueryprettyPhotoContact Form 7GoDaddy CoBlocksTwitter. What is Transgene's email format?
Transgene's email format typically follows the pattern of . Find more Transgene email formats with LeadIQ. How much funding has Transgene raised to date?
As of September 2024, Transgene has raised $16M in funding. The last funding round occurred on Jul 17, 2023 for $16M.When was Transgene founded?
Transgene was founded in 1979.
Company Overview
- Headquarters
- Illkirch-Graffenstaden, Bas-Rhin 67400 FR
- Phone number
- +33-3-88-27-9****
- Website
- transgene.fr
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 1979
- Employees
- 201-500
Media & News
Funding & Financials
- $16M
Transgene has raised a total of $16M of funding over 4 rounds. Their latest funding round was raised on Jul 17, 2023 in the amount of $16M.
- $50M$100M
Transgene's revenue is in the range of $50M$100M
Funding & Financials
- $16M
Transgene has raised a total of $16M of funding over 4 rounds. Their latest funding round was raised on Jul 17, 2023 in the amount of $16M.
- $50M$100M
Transgene's revenue is in the range of $50M$100M
Company Leadership
J. W.Chief Business Officer
S. R.Head Of Process Sciences- N. S.Head Of Vectorology Laboratory
- B. B.Head Of Biometry (biostatistics, Data Management)
- C. S.Head Of Toxicology
Employee Directory
- B. B.Head Of Biometry (biostatistics, Data Management)
- C. S.Head Of Toxicology
- E. B.Head Of Analytical (qc) Developement Department
- H. K.Head Of Department
- K. L.Head Of Program Management
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
